Expression Analysis Expands Affymetrix Capabilities
News Oct 13, 2005
Expression Analysis has concluded an upgrade of their laboratory systems to support the latest in Affymetrix high-content and specialty products.
“We've now completed the upgrade of our infrastructure to include the new Affymetrix 7G and MegAllele scanners, allowing us to process the newly released Affymetrix GeneChip® Exon Arrays, the Affymetrix GeneChip 500K Mapping Array Set and the MegAllele DME-T assay developed by ParAllele,” said Dr. Tom Goralski, Expression Analysis' Laboratory Director.
“These advancements give investigators additional tools to further enhance their genomic research and development efforts,” said Goralski.
The Affymetrix 7G GeneChip Scanner 3000 is designed to support the analysis of microarrays capable of providing up to 500% more data than previous versions.
The 500K Mapping Array Set enhances the ability to support high density genotyping studies on a significantly reduced "cost per SNP" basis.
The Exon Array provides researchers with exon-level expression profiling, allowing for the interrogation of over one million individual exons and splice variants across the entire human genome.
“The upgrades to our instruments and our Laboratory Information Management System were necessary to keep pace with advancements in genomic research,” said Steve Casey, Expression Analysis' founder and Chief Operating Officer.
“As the first microarray services company to obtain GLP compliance and CLIA registration, we are always looking to the future, to ensure we are ready and capable to support our clients' research requirements,” said Casey.
“We're proud to be able to once again take the lead in providing the scientific community access to the latest and best genomic technologies available.”
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE